Latest Articles

Publication Date
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer - geneonline.com

Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer geneonline.com

Published: Oct. 14, 2025, 6:39 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - Bioengineer.org

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival Bioengineer.org

Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - BIOENGINEER.ORG

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival BIOENGINEER.ORG

Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - bioengineer.org

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival bioengineer.org

Published: Oct. 14, 2025, 5:14 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org

Published: Oct. 14, 2025, 4:49 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG

Published: Oct. 14, 2025, 4:49 p.m.
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer - CancerNetwork

Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer CancerNetwork

Published: Oct. 13, 2025, 10:05 p.m.
Researchers awarded $11.2M grant to close endometrial cancer survival gap - UNC Gillings School of Global Public Health

Researchers awarded $11.2M grant to close endometrial cancer survival gap UNC Gillings School of Global Public Health

Published: Oct. 9, 2025, 4:10 p.m.
TGFB1/SMAD3-Driven Macrophage-Myofibroblast Transition Promotes Fibrosis Progression in Endometriosis.

Endometriosis is a chronic gynecological disorder characterized by progressive fibrosis, which is closely associated with clinical symptoms such as dysmenorrhea and infertility. While myofibroblast activation is central to fibrogenesis, the …

Published: Oct. 7, 2025, midnight
Molecular Pathogenesis of Ovarian Endometrioma: Mechanistic Insights and Therapeutic Implications.

Ovarian endometrioma (OMA), the most prevalent and clinically consequential subtype of endometriosis, represents a chronic inflammatory disorder characterized by ectopic endometrial-like lesions. This condition manifests as progressive dysmenorrhea, ovarian reserve …

Published: Oct. 4, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!